نتایج جستجو برای: pdgfra

تعداد نتایج: 1003  

2014
Dongfeng Chen Duo Zuo Cheng Luan Min Liu Manli Na Liang Ran Yingyu Sun Annette Persson Elisabet Englund Leif G. Salford Erik Renström Xiaolong Fan Enming Zhang

Increased PDGFRA signaling is an essential pathogenic factor in many subtypes of gliomas. In this context the cell surface expression of PDGFRA is an important determinant of ligand sensing in the glioma microenvironment. However, the regulation of spatial distribution of PDGFRA in glioma cells remains poorly characterized. Here, we report that cell surface PDGFRA expression in gliomas is negat...

2016
Carl Koschmann Daniel Zamler Alan MacKay Dan Robinson Yi-Mi Wu Robert Doherty Bernard Marini Dustin Tran Hugh Garton Karin Muraszko Patricia Robertson Marcia Leonard Lili Zhao Dale Bixby Luke Peterson Sandra Camelo-Piragua Chris Jones Rajen Mody Pedro R. Lowenstein Maria G. Castro

Pediatric high-grade glioma (HGG, WHO Grade III and IV) is a devastating brain tumor with a median survival of less than two years. PDGFRA is frequently mutated/ amplified in pediatric HGG, but the significance of this finding has not been fully characterized. We hypothesize that alterations of PDGFRA will promote distinct prognostic and treatment implications in pediatric HGG. In order to char...

2013
Dongfeng Chen Annette Persson Yingyu Sun Leif G. Salford David Gisselsson Nord Elisabet Englund Tao Jiang Xiaolong Fan

Signaling of platelet derived growth factor receptor alpha (PDGFRA) is critically involved in the development of gliomas. However, the clinical relevance of PDGFRA expression in glioma subtypes and the mechanisms of PDGFRA expression in gliomas have been controversial. Under the supervision of morphological diagnosis, analysis of the GSE16011 and the Repository of Molecular Brain Neoplasia Data...

2013
Jie Dai Yan Kong Lu Si Zhihong Chi Chuanliang Cui Xinan Sheng Lili Mao Siming Li Bin Lian Ruifeng Yang Shujing Liu Xiaowei Xu Jun Guo

Purpose: Platelet-derived growth factor receptor a (PDGFRA) is a target for tyrosine kinase inhibitor (TKI)-based targeted therapy. Dysregulation of PDGFRA has been reported in many cancers. However, PDGFRA mutations in melanomas have not been well studied. We analyzed the genetic mutations of PDGFRA in Chinese patients with melanoma and determined the inhibitory potency of TKIs, such as imatin...

2017
Jiangwei Lin Mona Khan Bolek Zapiec Peter Mombaerts

Extraembryonic endoderm stem (XEN) cell lines can be derived and maintained in vitro and reflect the primitive endoderm lineage. Platelet-derived growth factor receptor alpha (PDGFRA) is thought to be essential for the derivation and maintenance of mouse XEN cell lines. Here, we have re-evaluated this requirement for PDGFRA. We derived multiple PDGFRA-deficient XEN cell lines from postimplantat...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Michael C Heinrich Diana Griffith Arin McKinley Janice Patterson Ajia Presnell Abhijit Ramachandran Maria Debiec-Rychter

PURPOSE To determine the potential of crenolanib, a potent inhibitor of PDGFRA, to treat malignancies driven by mutant PDGFRA. EXPERIMENTAL DESIGN The biochemical activity of crenolanib was compared with imatinib using a panel of PDGFRA-mutant kinases expressed in several different cell line models, including primary gastrointestinal stromal tumors (GIST) cells. The antiproliferative activity...

Journal: :Blood 2011
Christian Elling Philipp Erben Christoph Walz Marie Frickenhaus Mirle Schemionek Martin Stehling Hubert Serve Nicholas C P Cross Andreas Hochhaus Wolf-Karsten Hofmann Wolfgang E Berdel Carsten Müller-Tidow Andreas Reiter Steffen Koschmieder

The FIP1L1-PDGFRA fusion is seen in a fraction of cases with a presumptive diagnosis of hypereosinophilic syndrome (HES). However, because most HES patients lack FIP1L1-PDGFRA, we studied whether they harbor activating mutations of the PDGFRA gene. Sequencing of 87 FIP1L1-PDGFRA-negative HES patients revealed several novel PDGFRA point mutations (R481G, L507P, I562M, H570R, H650Q, N659S, L705P,...

Journal: :Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 2012
Sara Jaramillo María José Ríos-Moreno Alicia Hernández Joaquín Amérigo Inmaculada Trigo-Sánchez Ricardo González-Cámpora

AIMS to determine whether potential correlations between CD117 and PDGFRA might serve as an indication for targeted therapies. MATERIAL AND METHODS immunohistochemical expression of CD117 and PDGFRA was evaluated in 99 paraffin-embedded GISTs in conjunction with KIT and PDGFRA mutational status. RESULTS CD117-positive staining was noted in 93 out of 99 cases. The predominant staining patter...

2007
Peggy Stock Dulabh Monga Xinping Tan Amanda Micsenyi Nick Loizos Satdarshan P.S. Monga

Hepatocellular cancer (HCC) is a disease of poor prognosis. Identifying novel molecular aberrations might present opportunities to identify new therapeutic targets. Due to the similarities between the processes of development and cancer, we used early developing livers to identify genes that might play a primary role in HCC. Plateletderived growth factor receptor-A (PDGFRA) was identified from ...

2017
Dongfeng Chen Annette Persson Yingyu Sun Leif G. Salford David Gisselsson Nord Elisabet Englund Tao Jiang Xiaolong Fan

Signaling of platelet derived growth factor receptor alpha (PDGFRA) is critically involved in the development of gliomas. However, the clinical relevance of PDGFRA expression in glioma subtypes and the mechanisms of PDGFRA expression in gliomas have been controversial. Under the supervision of morphological diagnosis, analysis of the GSE16011 and the Repository of Molecular Brain Neoplasia Data...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید